ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The ACS Division of Medicinal Chemistry has announced the winners of two division awards, which will be presented during the fall ACS national meeting in Boston.
Ann E. Weber, vice president for discovery and preclinical sciences and head of discovery chemistry at Merck Research Laboratories, is the winner of the Robert M. Scarborough Memorial Award for Excellence in Medicinal Chemistry. The award recognizes individuals who have led the discovery of novel therapeutic agents or who have made significant scientific discoveries that enhance the field of medicinal chemistry.
Weber has been involved in the design and synthesis of ligands for G-protein-coupled receptors, ion channels, and enzymes. Her research has resulted in 17 drug candidates in the areas of obesity, atherosclerosis, urinary incontinence, and pain. She also led the development of the diabetes drugs Januvia (sitagliptin phosphate) and Janumet (sitagliptin combined with metformin).
Andrew W. Stamford, a director of medicinal chemistry at Merck Research Laboratories, is the recipient of the 2010 David W. Robertson Award for Excellence in Medicinal Chemistry, which recognizes scientists under the age of 40 who have made seminal contributions to the discovery of novel therapeutic agents or who have made substantial contributions to and discoveries in medicinal chemistry.
Stamford’s research interests include the design and synthesis of enzyme inhibitors and of agonists and antagonists for G-protein-coupled receptors. His work has contributed to the identification of nine drug candidates in the areas of Alzheimer’s disease, Parkinson’s disease, obesity, and cardiovascular disease.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter